Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Chinese PLA General Hospital
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Hackensack Meridian Health
M.D. Anderson Cancer Center
University of Chicago
St. Jude Children's Research Hospital
Baptist Health South Florida
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
City of Hope Medical Center
Medical College of Wisconsin
St. Jude Children's Research Hospital
Roswell Park Cancer Institute
St. Jude Children's Research Hospital
University of California, San Francisco
University of Illinois at Chicago
Weill Medical College of Cornell University
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
Stanford University
M.D. Anderson Cancer Center
Thomas Jefferson University
H. Lee Moffitt Cancer Center and Research Institute
St. Jude Children's Research Hospital
Case Comprehensive Cancer Center
French Innovative Leukemia Organisation
Baylor College of Medicine
Children's Hospital Medical Center, Cincinnati
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
Therapeutic Advances in Childhood Leukemia Consortium
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center